Primary Site >> Colorectal Cancer
Gene >> AGER
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. PMID: 12579287 Ref: Differential effects between amphoterin and advanced glycation end products on colon cancer cells. PMID: 12640679 |
Ref: Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. PMID: 15743787 Ref: Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas. PMID: 15789216 Ref: Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients. PMID: 15823719 |
Ref: The role of trophinin, an adhesion molecule unique to human trophoblasts, in progression of colorectal cancer. PMID: 17487845 Ref: RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. PMID: 17587138 Ref: The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk. PMID: 17594690 |
Ref: RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. PMID: 18689872 |
Ref: RAGE signaling significantly impacts tumorigenesis and hepatic tumor growth in murine models of colorectal carcinoma. PMID: 20824364 |
Ref: Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer. PMID: 21527578 Ref: Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo. PMID: 21945853 |
Ref: Advanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose diet. PMID: 22467055 Ref: Plasma soluble receptor for advanced glycation end-products and risk of colorectal adenoma. PMID: 23205181 |
Ref: Rage signalling promotes intestinal tumourigenesis. PMID: 22469986 Ref: Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients. PMID: 23047645 Ref: Possible participation of receptor for advanced glycation end products (RAGE) in the origin of cancer stem cells in diabetic patients with colon cancer. PMID: 23466064 Ref: S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. PMID: 23693020 |
Ref: Cancer usurps skeletal muscle as an energy repository. PMID: 24197136 Ref: Gly82Ser polymorphism of the receptor for advanced glycation end-product (RAGE) potential high risk in patients with colorectal cancer. PMID: 24248547 Ref: Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process? PMID: 24484717 Ref: RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis. PMID: 24952599 |
Ref: High-mobility group box 1: a novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma. PMID: 25511739 Ref: Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma. PMID: 26009899 Ref: Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma. PMID: 26099505 Ref: The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells. PMID: 26193421 |
Ref: Clinical significance of AGE-RAGE axis in colorectal cancer: associations with glyoxalase-I, adiponectin receptor expression and prognosis. PMID: 26931562 Ref: Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma. PMID: 26975699 Ref: Mesenchymal-epithelial signalling in tumour microenvironment: role of high-mobility group Box 1. PMID: 26979829 Ref: A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women. PMID: 27100837 |
Ref: Glucose-derived AGEs promote migration and invasion of colorectal cancer by up-regulating Sp1 expression. PMID: 28237576 Ref: Expression of pattern recognition receptor genes and mortality in patients with colorectal adenocarcinoma. PMID: 28533893 |
Ref: RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review. PMID: 29987748 Ref: Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway. PMID: 30066846 Ref: Close interplay of nitro-oxidative stress, advanced glycation end products and inflammation in inflammatory bowel diseases. PMID: 30182837 Ref: HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer. PMID: 30258050 Ref: [A Case of Rectal Colon Cancer with Paraneoplastic Cerebellar Degeneration]. PMID: 30382061 |